A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)
- Conditions
- Lung CancerNon Small Cell Lung CancerBrain Metastases
- Interventions
- First Posted Date
- 2025-02-12
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 46
- Registration Number
- NCT06822543
Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer
- Conditions
- Prostate CancerHomologous Recombination DeficiencyCastrate Resistant Prostate Cancer
- Interventions
- Drug: Niraparib/Abirate rone acetate fixed-dose combination
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 70
- Registration Number
- NCT06527690
Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
- Conditions
- Carcinoma, Adrenocortical RecurrentCarcinoma Adrenal
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 150
- Registration Number
- NCT06279442
- Locations
- 🇧🇷
Pronutrir - Suporte Nutricional e Quimioterapia, Fortaleza, Ceará, Brazil
🇧🇷Hospital do Câncer do Maranhão Dr. Tarquínio Lopes Filho, São Luis, Maranhão, Brazil
🇧🇷Hospital Erasto Gaertner, Curitiba, Paraná, Brazil
Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade
- First Posted Date
- 2023-10-05
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 63
- Registration Number
- NCT06068985
- Locations
- 🇧🇷
NOB - Núcleo de Oncologia da Bahia (Oncoclínicas), Salvador, Bahia, Brazil
🇧🇷Oncocentro de Minas Gerais (Oncoclínicas), Belo Horizonte, Minas Gerais, Brazil
🇧🇷CPO - Centro de Pesquisa em Oncologia do Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil
Molecular Characterization of Penile Cancers in Developing Countries
- Conditions
- Penile Squamous Cell Carcinoma
- First Posted Date
- 2023-10-05
- Last Posted Date
- 2023-10-05
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 24
- Registration Number
- NCT06068998
- Locations
- 🇧🇷
Oncocentro Ceará, Fortaleza, Ceará, Brazil
🇧🇷Hospital Universitário da Universidade Federal do Maranhão (UFMA), São Luís, Maranhão, Brazil
🇧🇷Centro de Pesquisa em Oncologia do Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil
Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil
- Conditions
- Endometrial Cancer
- Interventions
- Other: Observational study
- First Posted Date
- 2023-08-28
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 276
- Registration Number
- NCT06014580
- Locations
- 🇧🇷
Santa Casa de Misericórdia de Feira de Santana, Feira De Santana, Bahia, Brazil
🇧🇷ICC - Instituto do Câncer do Ceará, Fortaleza, Ceará, Brazil
🇧🇷Hospital Evangélico de Cachoeiro de Itapemirim - Centro de Pesquisas Clínicas em Oncologia (CPCO), Cachoeiro De Itapemirim, Espírito Santo, Brazil
A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil
- Conditions
- Extensive-stage Small-cell Lung Cancer
- Interventions
- Other: Observational study
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 60
- Registration Number
- NCT06008353
- Locations
- 🇧🇷
ÉTICA Clínica AMO - Assistência Multidisciplinar em Oncologia, Salvador, Bahia, Brazil
🇧🇷Oncologia D'Or Unidade Esperança Pernambuco, Recife, Pernambuco, Brazil
🇧🇷Instituto D'Or de Pesquisa e Ensino RJ, Rio De Janeiro, Brazil
Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America
- Conditions
- Gastric CancerGastroEsophageal CancerPancreatic Cancer
- Interventions
- Other: Observational study
- First Posted Date
- 2023-06-29
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 120
- Registration Number
- NCT05924789
- Locations
- 🇦🇷
Instituto de Oncología San Gerónimo, Santa Fe de la Vera Cruz, Santa Fé, Argentina
🇧🇷ÉTICA Clínica AMO - Assistência Multidisciplinar em Oncologia, Salvador, Bahia, Brazil
🇧🇷HMV - Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil
A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America
- Conditions
- Ovarian Cancer
- Interventions
- Other: Observational study
- First Posted Date
- 2023-05-12
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 64
- Registration Number
- NCT05857397
- Locations
- 🇦🇷
COIP - Centro Oncologico Integral Pampeano, Santa Rosa, La Pampa, Argentina
🇦🇷Sanatorio de la Mujer, Rosario, Santa Fé, Argentina
🇦🇷Fundacion Medica de Rio Negro y Neuquen, Neuquén, Argentina
Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study
- Conditions
- Radiotherapy Side Effect
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 400
- Registration Number
- NCT05776147
- Locations
- 🇧🇷
ICC - Instituto do Câncer do Ceará, Fortaleza, Ceará, Brazil
🇧🇷Hospital Sírio-Libanês DF, Brasília, Distrito Federal, Brazil
🇧🇷Hospital Márcio Cunha da Fundação São Francisco Xavier (HMC-FSFX), Ipatinga, Minas Gerais, Brazil